The epidemiology of genital human papillomavirus infection

Vaccine

Volumn 24, Issue SUPPL. 1, 2006, Pages S4-

  Trottier, Helen ^a   Franco, Eduardo L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cervical cancer; Epidemiology; Genital human papillomavirus

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; LEUKOCYTE ANTIGEN; ORAL CONTRACEPTIVE AGENT; WART VIRUS VACCINE;

CANCER RISK; CIGARETTE SMOKING; DIETARY INTAKE; DIGESTIVE SYSTEM CANCER; GENITAL TRACT INFECTION; GENITAL TRACT TUMOR; GONORRHEA; HEALTH CARE SYSTEM; HUMAN; MORBIDITY; PARITY; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS INFECTION; VIRUS TRANSMISSION; WART VIRUS;

EID: 33644933659     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.09.054     Document Type: Article

References (103)

1. E.M. De Villiers, K. Gunst, H. Stein, and H. Scherubl Esophageal squamous cell cancer in patients with head and neck cancer: prevalence of human papillomavirus DNA sequences Int J Cancer 109 2 2004 253 258
2. H. zur Hausen Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis J Natl Cancer Inst 92 9 2000 690 698
3. IARC. Epidemiology of infection: human papillomaviruses. Carcinog Risk Chem Hum 1995;64:60-5.
4. K. Gjooen, A.O. Olsen, P. Magnus, B. Grinde, T. Sauer, and I. Orstavik Prevalence of human papillomavirus in cervical scrapes, as analyzed by PCR, in a population-based sample of women with and without cervical dysplasia APMIS 104 1 1996 68 74
5. E.L. Franco, L.L. Villa, H. Richardson, T. Rohan, and A. Ferenczy Epidemiology of cervical human papillomavirus infection E. Franco J. Monsonego New developments in cerivical cancer screening and prevention 1997 Blackwell Science Oxford, UK 14 22
6. J.G. Baseman, and L.A. Koutsky The epidemiology of human papillomavirus infections J Clin Virol 32 Suppl. 1 2005 S16 S24
7. F.X. Bosch, and S.S. de Human papillomavirus and cervical cancer - burden and assessment of causality J Natl Cancer Inst Monogr 31 2003 3 13 [chapter 1]
8. H. Richardson, G. Kelsall, P. Tellier, H. Voyer, M. Abrahamowicz, and A. Ferenczy The natural history of type-specific human papillomavirus infections in female university students Cancer Epidemiol Biomarkers Prev 12 6 2003 485 490
9. R. Herrero, P.E. Castle, M. Schiffman, M.C. Bratti, A. Hildesheim, and J. Morales Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica J Infect Dis 191 11 2005 1796 1807
10. M.H. Schiffman Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia J Natl Cancer Inst 84 6 1992 394 398
11. S.K. Kjaer, B. Chackerian, A.J. van den Brule, E.I. Svare, G. Paull, and J.M. Walbomers High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse) Cancer Epidemiol Biomarkers Prev 10 2 2001 101 106
12. S.K. Kjaer, E.I. Svare, A.M. Worm, J.M. Walboomers, C.J. Meijer, and A.J. van den Brule Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity Sex Transm Dis 27 8 2000 438 445
13. P.E. Castle, M. Schiffman, R. Herrero, A. Hildesheim, A.C. Rodriguez, and M.C. Bratti A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica J Infect Dis 191 11 2005 1808 1816
14. R. Herrero, A. Hildesheim, C. Bratti, M.E. Sherman, M. Hutchinson, and J. Morales Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica J Natl Cancer Inst 92 6 2000 464 474
15. E. Lazcano-Ponce, R. Herrero, N. Munoz, A. Cruz, K.V. Shah, and P. Alonso Epidemiology of HPV infection among Mexican women with normal cervical cytology Int J Cancer 91 3 2001 412 420
16. E.M. Smith, S.R. Johnson, J.M. Ritchie, D. Feddersen, D. Wang, and L.P. Turek Persistent HPV infection in postmenopausal age women Int J Gynaecol Obstet 87 2 2004 131 137
17. E.L. Franco, L.L. Villa, J.P. Sobrinho, J.M. Prado, M.C. Rousseau, and M. Desy Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer J Infect Dis 180 5 1999 1415 1423
18. N. Munoz, F. Mendez, H. Posso, M. Molano, A.J. van den Brule, and M. Ronderos Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results J Infect Dis 190 12 2004 2077 2087
19. Centers for Disease Control and Prevention. Genital HPV Infection - CDC Fact Sheet. Centers for Disease Control and Prevention; 2004. Available from: URL: http://www.cdc.gov/std/HPV/STDFact-HPV.htm.
20. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5, Version 2.0, IARC Press, Lyon, 2004-2005.
21. A. Jemal, T. Murray, E. Ward, A. Samuels, R.C. Tiwari, and A. Ghafoor Cancer statistics CA Cancer J Clin 55 1 2005 10 30
22. E.L. Franco, E. Duarte-Franco, and A. Ferenczy Prospects for controlling cervical cancer at the turn of the century Salud Publica Mex 45 Suppl. 3 2003 S367 S375
23. WHO Vaccine Report. The current status of development of prophylactic vaccines against human papillomavirus infection. Report of a technical meeting. World Health Organization; 1999. Available from: URL: http://www.who.int/ vaccine_research/documents/en/hpv1.pdf.
24. H. zur Hausen Papillomavirus infections - a major cause of human cancers Biochim Biophys Acta 1288 2 1996 F55 F78
25. A. Spence, E. Franco, and A. Ferenczy The role of human papillomaviruses in cancer: evidence to date Am J Cancer 4 2005 49 64
26. L.A. Koutsky, D.A. Galloway, and K.K. Holmes Epidemiology of genital human papillomavirus infection Epidemiol Rev 10 1988 122 163
27. T.Y. Chuang, H.O. Perry, L.T. Kurland, and D.M. Ilstrup Condyloma acuminatum in Rochester, Minn., 1950-1978. I. Epidemiology and clinical features Arch Dermatol 120 4 1984 469 475
28. E. Franco Epidemiology of anogential warts and cancer R. Reid A. Lorincz Human papillomaviruses I 1996 WB Saunders Philadelphia, PA 597 623
29. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2003. US Department of Health and Human Services; 2004.
30. G.Y. Ho, R. Bierman, L. Beardsley, C.J. Chang, and R.D. Burk Natural history of cervicovaginal papillomavirus infection in young women N Engl J Med 338 7 1998 423 428
31. R.L. Winer, S.K. Lee, J.P. Hughes, D.E. Adam, N.B. Kiviat, and L.A. Koutsky Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students Am J Epidemiol 157 3 2003 218 226
32. C.B. Woodman, S. Collins, H. Winter, A. Bailey, J. Ellis, and P. Prior Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study Lancet 357 9271 2001 1831 1836
33. A.R. Giuliano, M. Papenfuss, M. Abrahamsen, and P. Inserra Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border Cancer Epidemiol Biomarkers Prev 11 9 2002 930 934
34. A.R. Giuliano, R. Harris, R.L. Sedjo, S. Baldwin, D. Roe, and M.R. Papenfuss Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study J Infect Dis 186 4 2002 462 469
35. N. Munoz, F.X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, and K.V. Shah Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 6 2003 518 527
36. A. Hildesheim, M.H. Schiffman, P.E. Gravitt, A.G. Glass, C.E. Greer, and T. Zhang Persistence of type-specific human papillomavirus infection among cytologically normal women J Infect Dis 169 2 1994 235 240
37. A.B. Moscicki, S. Shiboski, J. Broering, K. Powell, L. Clayton, and N. Jay The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women J Pediatr 132 2 1998 277 284
38. M. Molano, A. Van den Brule, M. Plummer, E. Weiderpass, H. Posso, and A. Arslan Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study Am J Epidemiol 158 5 2003 486 494
39. L.A. Koutsky, K.K. Holmes, C.W. Critchlow, C.E. Stevens, J. Paavonen, and A.M. Beckmann A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection N Engl J Med 327 18 1992 1272 1278
40. G.Y. Ho, R.D. Burk, S. Klein, A.S. Kadish, C.J. Chang, and P. Palan Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia J Natl Cancer Inst 87 18 1995 1365 1371
41. K.L. Wallin, F. Wiklund, T. Angstrom, F. Bergman, U. Stendahl, and G. Wadell Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer N Engl J Med 341 22 1999 1633 1638
42. N. Ylitalo, A. Josefsson, M. Melbye, P. Sorensen, M. Frisch, and P.K. Andersen A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ Cancer Res 60 21 2000 6027 6032
43. K.L. Liaw, A.G. Glass, M.M. Manos, C.E. Greer, D.R. Scott, and M. Sherman Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions J Natl Cancer Inst 91 11 1999 954 960
44. M.A. Nobbenhuis, J.M. Walboomers, T.J. Helmerhorst, L. Rozendaal, A.J. Remmink, and E.K. Risse Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study Lancet 354 9172 1999 20 25
45. N.F. Schlecht, S. Kulaga, J. Robitaille, S. Ferreira, M. Santos, and R.A. Miyamura Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia JAMA 286 24 2001 3106 3114
46. S.K. Kjaer, A.J. van den Brule, G. Paull, E.I. Svare, M.E. Sherman, and B.L. Thomsen Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study BMJ 325 7364 2002 572
47. M. Schiffman, and P.E. Castle Human papillomavirus: epidemiology and public health Arch Pathol Lab Med 127 8 2003 930 934
48. E.L. Franco, L.L. Villa, P. Rahal, and A. Ruiz Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection J Natl Cancer Inst 86 20 1994 1558 1559
49. L.L. Villa, L. Sichero, P. Rahal, O. Caballero, A. Ferenczy, and T. Rohan Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia J Gen Virol 81 Pt 12 2000 2959 2968
50. J. Brisson, I. Bairati, C. Morin, M. Fortier, C. Bouchard, and A. Christen Determinants of persistent detection of human papillomavirus DNA in the uterine cervix J Infect Dis 173 4 1996 794 799
51. M.C. Rousseau, J.S. Pereira, J.C. Prado, L.L. Villa, T.E. Rohan, and E.L. Franco Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection J Infect Dis 184 12 2001 1508 1517
52. K.K. Thomas, J.P. Hughes, J.M. Kuypers, N.B. Kiviat, S.K. Lee, and D.E. Adam Concurrent and sequential acquisition of different genital human papillomavirus types J Infect Dis 182 4 2000 1097 1102
53. M.C. Rousseau, M. Abrahamowicz, L.L. Villa, M.C. Costa, T.E. Rohan, and E.L. Franco Predictors of cervical coinfection with multiple human papillomavirus types Cancer Epidemiol Biomarkers Prev 12 10 2003 1029 1037
54. C. Perrons, R. Jelley, B. Kleter, W. Quint, and N. Brink Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA J Clin Virol 32 4 2005 278 285
55. M.C. Rousseau, E.L. Franco, L.L. Villa, J.P. Sobrinho, L. Termini, and J.M. Prado A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections Cancer Epidemiol Biomarkers Prev 9 5 2000 469 476
56. K.L. Liaw, A. Hildesheim, R.D. Burk, P. Gravitt, S. Wacholder, and M.M. Manos A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types J Infect Dis 183 1 2001 8 15
57. H. zur Hausen Condylomata acuminata and human genital cancer Cancer Res 36 2, Pt 2 1976 794
58. E.L. Franco Viral etiology of cervical cancer: a critique of the evidence Rev Infect Dis 13 6 1991 1195 1206
59. N. Munoz, X. Bosch, and J.M. Kaldor Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence Br J Cancer 57 1 1988 1 5
60. N. Munoz, F.X. Bosch, S. Desanjose, L. Tafur, I. Izarzugaza, and M. Gili The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain Int J Cancer 52 5 1992 743 749
61. M.H. Schiffman, H.M. Bauer, R.N. Hoover, A.G. Glass, D.M. Cadell, and B.B. Rush Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia J Natl Cancer Inst 85 12 1993 958 964
62. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, and K.V. Shah Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1 1999 12 19
63. F.X. Bosch, A. Lorincz, N. Munoz, C.J. Meijer, and K.V. Shah The causal relation between human papillomavirus and cervical cancer J Clin Pathol 55 4 2002 244 265
64. J.M. Walboomers, and C.J. Meijer Do HPV-negative cervical carcinomas exist? J Pathol 181 3 1997 253 254
65. V. Cogliano, R. Baan, K. Straif, Y. Grosse, B. Secretan, and G.F. El Carcinogenicity of human papillomaviruses Lancet Oncol 6 4 2005 204
66. IARC. Human Papillomaviruses. IARC monographs on the evaluation of carcinogenic risks to humans; 2005.
67. L. Koutsky Epidemiology of genital human papillomavirus infection Am J Med 102 5A 1997 3 8
68. A.B. Moscicki, N. Hills, S. Shiboski, K. Powell, N. Jay, and E. Hanson Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females JAMA 285 23 2001 2995 3002
69. J.W. Sellors, T.L. Karwalajtys, J. Kaczorowski, J.B. Mahony, A. Lytwyn, and S. Chong Incidence, clearance and predictors of human papillomavirus infection in women CMAJ 168 4 2003 421 425
70. J.G. Baseman, and L.A. Koutsky The epidemiology of human papillomavirus infections J Clin Virol 32 Suppl. 1 2005 S16 S24
71. E.L. Franco, L.L. Villa, A. Ruiz, and M.C. Costa Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types J Infect Dis 172 3 1995 756 763
72. S.K. Kjaer, A.J. van den Brule, J.E. Bock, P.A. Poll, G. Engholm, and M.E. Sherman Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev 6 10 1997 799 805
73. H. Richardson, E. Franco, J. Pintos, J. Bergeron, M. Arella, and P. Tellier Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal University students Sex Transm Dis 27 2 2000 79 86
74. H. Richardson, E. Franco, J. Pintos, J. Bergeron, M. Arella, and P. Tellier Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal University students Sex Transm Dis 27 2 2000 79 86
75. S.O. Aral, and K.K. Holmes Social and behavioural determinants of epidemiology of STDs: industrialized and developing countries K.K. Holmes P. Mardh P.F. Sparling Sexually transmitted diseases 3rd ed. 1999 McGraw-Hill New York 39 76
76. J.A. Kahn, S.L. Rosenthal, P.A. Succop, G.Y. Ho, and R.D. Burk Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection Pediatrics 109 1 2002 E5
77. L.E. Manhart, and L.A. Koutsky Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis Sex Transm Dis 29 11 2002 725 735
78. K.M. Stone, J. Timyan, and E.L. Thomas Barrier methods for the prevention of sexually transmitted diseases K.K. Holmes P. Mardh P.F. Sparling Sexually transmitted diseases 3rd ed. 1999 McGraw-Hill New York 1307 1321
79. S.O. Aral, and T.A. Peterman A stratified approach to untangling the behavioral/biomedical outcomes conundrum Sex Transm Dis 29 9 2002 530 532
80. M. Macaluso, M.J. Demand, L.M. Artz, and E.W. Hook III Partner type and condom use AIDS 14 5 2000 537 546
81. L. Warner, D.R. Newman, H.D. Austin, M.L. Kamb, J.M. Douglas Jr., and C.K. Malotte Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status Am J Epidemiol 159 3 2004 242 251
82. C. Sonnex, S. Strauss, and J.J. Gray Detection of human papillomavirus DNA on the fingers of patients with genital warts Sex Transm Infect 75 5 1999 317 319
83. L. Ahdieh, R.S. Klein, R. Burk, S. Cu-Uvin, P. Schuman, and A. Duerr Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women J Infect Dis 184 6 2001 682 690
84. R. Garcia-Closas, X. Castellsague, X. Bosch, and C.A. Gonzalez The role of diet and nutrition in cervical carcinogenesis: A review of recent evidence Int J Cancer 117 4 2005 629 637
85. A.R. Giuliano, E.M. Siegel, D.J. Roe, S. Ferreira, M.L. Baggio, and L. Galan Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig-McGill HPV Natural History Study J Infect Dis 188 2003 1508 1516
86. H. Richardson, M. Abrahamowicz, P.P. Tellier, G. Kelsall, R. du Berger, and A. Ferenczy Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students Cancer Epidemiol Biomarkers Prev 14 5 2005 1149 1156
87. N.F. Schlecht, A. Trevisan, E. Duarte-Franco, T.E. Rohan, A. Ferenczy, and L.L. Villa Viral load as a predictor of the risk of cervical intraepithelial neoplasia Int J Cancer 103 4 2003 519 524
88. S.S. Wang, and A. Hildesheim Viral and host factors in human papillomavirus persistence and progression J Natl Cancer Inst Monogr 31 2003 35 40 [chapter 5]
89. P.C. Maciag, N.F. Schlecht, P.S. Souza, T.E. Rohan, E.L. Franco, and L.L. Villa Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection J Infect Dis 186 2 2002 164 172
90. A.T. Lorincz, R. Reid, A.B. Jenson, M.D. Greenberg, W. Lancaster, and R.J. Kurman Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types Obstet Gynecol 79 3 1992 328 337
91. H.M. Bauer, A. Hildesheim, M.H. Schiffman, A.G. Glass, B.B. Rush, and D.R. Scott Determinants of genital human papillomavirus infection in low-risk women in Portland Oregon. Sex Transm Dis 20 5 1993 274 278
92. I. Nindl, A. Lorincz, I. Mielzynska, U. Petry, S. Baur, and R. Kirchmayr Human papillomavirus detection in cervical intraepithelial neoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods Clin Diagn Virol 10 1 1998 49 56
93. F.X. Bosch, M.M. Manos, N. Munoz, M. Sherman, A.M. Jansen, and J. Peto Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group J Natl Cancer Inst 87 11 1995 796 802
94. S. Syrjanen, I. Shabalova, N. Petrovichev, J. Podistov, O. Ivanchenko, and S. Zakharenko Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union Int J STD AIDS 16 3 2005 217 223
95. S.A. Hinchliffe, V.D. van, H. Korporaal, P.L. Kok, and M.E. Boon Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology Br J Cancer 72 4 1995 943 945
96. M. Evander, K. Edlund, A. Gustafsson, M. Jonsson, R. Karlsson, and E. Rylander Human papillomavirus infection is transient in young women: a population-based cohort study J Infect Dis 171 4 1995 1026 1030
97. K. Elfgren, M. Kalantari, B. Moberger, B. Hagmar, and J. Dillner A population-based five-year follow-up study of cervical human papillomavirus infection Am J Obstet Gynecol 183 3 2000 561 567
98. K. Elfgren, M. Jacobs, J.M. Walboomers, C.J. Meijer, and J. Dillner Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia Obstet Gynecol 100 5, Pt 1 2002 965 971
99. L.F. Xi, J.J. Carter, D.A. Galloway, J. Kuypers, J.P. Hughes, and S.K. Lee Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students Cancer Epidemiol Biomarkers Prev 11 4 2002 343 351
100. V. Dalstein, D. Riethmuller, J.L. Pretet, K. Le Bail Carval, J.L. Sautiere, and J.P. Carbillet Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study Int J Cancer 106 3 2003 396 403
101. S. de Sanjose, F.X. Bosch, L.A. Tafur, C.M. Nascimento, I. Izarzugaza, and A. Izquierdo Clearance of HPV infection in middle aged men and women after 9 years' follow up Sex Transm Infect 79 4 2003 348
102. A.B. Moscicki, J.H. Ellenberg, S. Farhat, and J. Xu Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type J Infect Dis 190 1 2004 37 45
103. D.R. Brown, M.L. Shew, B. Qadadri, N. Neptune, M. Vargas, and W. Tu A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women J Infect Dis 191 2 2005 182 192